日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual Topoisomerase Inhibitor Is Highly Potent and Improves Antitumor Response to Radiotherapy in Cervical Carcinoma.

双重拓扑异构酶抑制剂效力极强,可提高宫颈癌放射治疗的抗肿瘤反应

Flörkemeier Inken, Hotze Hannah L, Heyne Anna Lena, Hildebrandt Jonas, Weimer Jörg P, Hedemann Nina, Rogmans Christoph, Holthaus David, Siebert Frank-André, Hirt Markus, Polten Robert, Morgan Michael, Klapdor Rüdiger, Schambach Axel, Dempfle Astrid, Maass Nicolai, van Mackelenbergh Marion T, Clement Bernd, Bauerschlag Dirk O

In Vivo and In Vitro Pharmacokinetic Studies of a Dual Topoisomerase I/II Inhibitor.

双重拓扑异构酶 I/II 抑制剂的体内和体外药代动力学研究

Hildebrandt Jonas, Bauerschlag Dirk O, Fricker Gert, Girreser Ulrich, Konukiewitz Björn, Kellers Franziska, Maass Nicolai, Clement Bernd, Flörkemeier Inken

[Scientific basics of pharmacist education]

【药剂师教育的科学基础】

Clement, Bernd

mARC1 Is the Main Contributor to Metabolic Reduction of N-Hydroxyurea.

mARC1 是 N-羟基脲代谢还原的主要贡献者

Klopp Cathrin, Zhang Xiaomei, Campbell Morgan K, Kvaskoff David, Struwe Michel A, Warren Curtis R, Bajrami Besnik, Scheidig Axel J, Jones Amanda K, Clement Bernd

mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes

mARC1在MASLD中的作用:调节人肝细胞和脂肪细胞中的脂质积累

Jones, Amanda K; Bajrami, Besnik; Campbell, Morgan K; Erzurumluoglu, Abdullah Mesut; Guo, Qiusha; Chen, Hongxing; Zhang, Xiaomei; Zeveleva, Svetlana; Kvaskoff, David; Brunner, Andreas-David; Muller, Stefanie; Gathey, Vasudha; Dave, Rajvee M; Tanner, James W; Rixen, Sophia; Struwe, Michel A; Phoenix, Kathryn; Klumph, Kaitlyn J; Robinson, Heather; Veyel, Daniel; Muller, Annkatrin; Noyvert, Boris; Bartholdy, Boris Alexander; Steixner-Kumar, Agnes A; Stutzki, Jan; Drichel, Dmitriy; Omland, Steffen; Sheehan, Ryan; Hill, Jon; Bretschneider, Tom; Gottschling, Dirk; Scheidig, Axel J; Clement, Bernd; Giera, Martin; Ding, Zhihao; Broadwater, John; Warren, Curtis R

Active Site Structures of the Escherichia coli N-Hydroxylaminopurine Resistance Molybdoenzyme YcbX

大肠杆菌N-羟基氨基嘌呤抗性钼酶YcbX的活性位点结构

Yang, Jing; Struwe, Michel; Scheidig, Axel; Mengell, Joshua; Clement, Bernd; Kirk, Martin L

The History of mARC

mARC 的历史

Clement, Bernd; Struwe, Michel A

Reduction of Hydrogen Peroxide by Human Mitochondrial Amidoxime Reducing Component Enzymes

人线粒体酰胺肟还原组分酶对过氧化氢的还原作用

Rixen, Sophia; Indorf, Patrick M; Kubitza, Christian; Struwe, Michel A; Klopp, Cathrin; Scheidig, Axel J; Kunze, Thomas; Clement, Bernd

The mitochondrial amidoxime reducing component-from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target

线粒体酰胺肟还原组分——从前药激活机制到药物代谢酶,再到药物靶点

Struwe, Michel A; Scheidig, Axel J; Clement, Bernd

Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein

致编辑的信:具有临床意义的MTARC1 p.Ala165Thr变异既不影响人mARC1蛋白的折叠,也不影响其活性位点结构。

Struwe, Michel A; Clement, Bernd; Scheidig, Axel